II

103D CONGRESS

2D SESSION S. 2046

To amend the Public Health Service Act to provide for the establishment

by the National Institutes of Health of research centers regarding movement disorders, and for other purposes.

IN THE SENATE OF THE UNITED STATES

APRIL 26 (legislative day, APRIL 11), 1994

Mr. COCHRAN introduced the following bill; which was read twice and referred

to the Committee on Labor and Human Resources

A BILL

To amend the Public Health Service Act to provide for

the establishment by the National Institutes of Health

of research centers regarding movement disorders, and

for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Movement Disorders

5 Research Amendments of 1993’’.
2

•S 2046 IS

1 SEC. 2. ESTABLISHMENT OF AUTHORITY FOR RESEARCH

2 CENTERS REGARDING MOVEMENT DIS3 ORDERS.

4 Part B of title IV of the Public Health Service Act

5 (42 U.S.C. 284 et seq.), as amended by section 302 of

6 Public Law 103–43 (107 Stat. 151), is amended by insert7 ing after section 409A the following new section:

8 ‘‘RESEARCH CENTERS REGARDING MOVEMENT

9 DISORDERS

10 ‘‘SEC. 409B. (a) The Director of NIH, acting

11 through the Directors of the appropriate national research

12 institutes and after consultation with the advisory councils

13 for such institutes, may make grants to, or enter into con14 tracts with, public or nonprofit private entities for the de15 velopment and operation of centers to conduct basic and

16 clinical research on movement disorders, including but not

17 limited to the conditions specified in subsection (b).

18 ‘‘(b) The conditions specified in this subsection are

19 as follows:

20 ‘‘(1) Various dystonias, including

21 blepharospasm, spasmodic dysphonia, spasmodic

22 torticollis, and Meige syndrome.

23 ‘‘(2) Huntington’s disease and other choreas,

24 including sydenham chorea, senile chorea, and

25 tardive dyskinesia.
3

•S 2046 IS

1 ‘‘(3) Myoclonus, Parkinson’s disease, progres2 sive supranuclear palsy, Rett syndrome, Shy-Drager

3 syndrome, tics and tourette syndrome, essential

4 tremor, and Wilson’s disease.

5 ‘‘(c) Each center assisted under this section shall use

6 the facilities of a single institution, or be formed from a

7 consortium of cooperating institutions, meeting such re8 quirements as may be prescribed by the Director of NIH.

9 ‘‘(d) Support of a center under this section may be

10 for a period not exceeding 5 years. Such period may be

11 extended for one or more additional periods not exceeding

12 5 years if the operations of such center have been reviewed

13 by an appropriate technical and scientific peer review

14 group established by the Director of NIH and if such

15 group has recommended to the Director that such period

16 should be extended.

17 ‘‘(e) No amounts are authorized to be appropriated

18 under this section. This section may be carried out only

19 with amounts that are otherwise appropriated for activi20 ties of the National Institutes of Health and that, as pro21 vided in appropriations Acts, are available for the grants

22 and contracts described in subsection (a).’’.

Æ